AJMC Staff

Knowing who may respond to tildrakizumab early on may help providers and patients decide whether to continue with treatment, the researchers said.

EpiPen manufacturer settles $30 million claim; THC-containing brands cited as potential cause of vaping epidemic; Idaho submits work-requirement waiver for Medicaid expansion.

The new indication is the seventh overall for the therapy, according to Janssen.

The CDC reports a 52% rise in vaping-related illnesses from last week; bundled payment models are being tried for maternity care costs; the chief executive officer of Blue Cross and Blue Shield of North Carolina has resigned and a merger put on hold after news of his alleged alcohol-related crash 3 months ago became public.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Researchers studied a particular mutation in a gene linked to Parkinson.

The Sandoz unit of Novartis has expanded its recall of its heartburn medications containing ranitidine; Juul Labs announced that their chief executive offer is stepping down and that the company would not lobby the Trump administration on its impending ban of flavored vaping products; Amazon has launched a virtual medical clinic for its employees in Seattle.

Federal prosecutors in California are opening a federal probe into Juul Labs; the FDA has approved the first vaccine for smallpox and monkeypox; an analysis from the Congressional Budget Office finds that an approach to address surprise medical bills backed by doctors would cost the government billions.

Recall for blood pressure medication losartan has expanded for a fifth time; the lead crisis in Newark is easing after significant filter results for water; allergists speak about the pros and cons of the potential first peanut allergy treatment.

A recent study indicates that the level of job satisfaction among patients with migraine influences the impact of perceived disability on work productivity.

Walmart announces it will stop selling e-cigarettes; Sutter Health antitrust case begins its jury selection today; Bernie Sanders proposes plan to eliminate $81 billion in medical debt.

Psoriasis is known to be linked with metabolic syndrome, which is triggered by chronic inflammation and fosters obesity and dyslipidemia. A recent study looked at another chronic inflammatory skin disease, lichen planus, to better understand any associations with metabolic syndrome.

Vaping-related lung illnesses have risen to 530 cases; 2 invasive species of mosquitoes are spreading across California; US pays $3 million toward research on medicinal marijuana.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

More women and their children are surviving today than ever before; the FDA has been quietly pressuring several companies to stop offering patients genetic test results that indicate how their genes may react to certain drugs; there has been an uptick in the number of US illnesses and deaths resulting from a rare mosquito-borne virus.

Terazosin, a drug used to treat enlarged prostate, may also be able to slow the progression of Parkinson disease.

Tennessee has unveiled its proposal to turn the state's Medicaid program into a block grant; the number of abortions across the country have dropped to the lowest levels since the procedure became legal nationwide; New York has temporaily banned the sale of e-cigarettes and nicotine e-liquids.

The FDA grants fast track designation of AstraZeneca's dapagliflozin; California to conduct public awareness campaign against vaping; no new US measles cases.

Amgen recently announced early phase 3 CANDOR study data, showing the triple-drug combination of carfilzomib (Kyprolis), along with dexamethasone and daratumumab (Darzalex, sold by Janssen), met its primary end point of progression-free survival in patients with relapsed or refractory multiple myeloma, with a 37% reduction in the risk of progression or death.

Oxycontin manufacturer Purdue Pharma files for bankruptcy; the rise in uninsured immigrants may be associated with fear of the Trump administration's crackdown on immigrants; an investigation has found that some cannabidiol (CBD) products are being spiked in Maryland.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A CRISPR therapy for a man with HIV has resulted in no side effects but is ineffective; nursing facilities are a breeding ground for drug-resistant germs; Walmart has opened its first “Walmart Health” center, offering a variety of health services.

The family that owns the drug company at the center of the nation’s opioid problem reached a tentative settlement with thousands of municipal governments and nearly 2 dozen states that sued the pharma industry for its role in creating the crisis; nearly 8 in 10 Americans back legislation to protect people from surprise medical bills; the water crisis in Flint, Michigan, was not only about lead in the water—it was also about a deadly outbreak of Legionnaires’ disease.

Health insurers will shell out $743 million in rebates to consumers under an Affordable Care Act (ACA) rule; the human papilloma virus (HPV) vaccine offers benefits to men who are not vaccinated; Apple is launching 3 studies to assess the Apple Watch’s ability to monitor health and medical conditions.

Juul is being investigated for making unauthorized safety claims, while the governor of New York proposes to ban flavored e-cigarettes; Sutter Health is being sued for its role in rising healthcare costs; a European doctor who uses telemedicine and internet prescribing to provide American women with mifepristone and misoprostol to induce abortion in the first trimester is suing the FDA.

Oxycontin manufacturer rejects settlement for role in opioid epidemic and moves toward bankruptcy; new vaping-related respiratory illnesses reported; Senator Kamala Harris, D-California, a 2020 presidential candidate, proposes a new healthcare plan for veterans.

A recent study explored the efficacy of brentuximab vedotin (BV) in patients with high-CD30–expressing non-Hodgkin lymphoma (NHL) to determine who is most likely to benefit.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Health officials in New York are investigating vitamin E's connection to a string of vaping illnesses in the state; civil rights groups are suing the Trump administration over its decision to deport immigrants with life-threatening illnesses; an oncologist from MD Anderson Cancer Center met with President Trump about a potential nomination for FDA commissioner.

A federal judge has ruled that CVS' purchase of Aetna was legal under antitrust law; the Trump administration announced $1.8 billion in grants to help states and communities combat the opioid epidemic; Johns Hopkins Medicine has launched the first psychedelic research center in the United States.